12,352.35-3.15
Stock Analysis, IPO, Mutual Funds, Bonds & More

AI-based retinal diagnostic startup Leben Care gets funded by IP Ventures

Leben Care enables automated analysis of retina image using AI algorithms that can be used by technicians, optometrists to conduct basic screening with minimal specialist intervention.

ET Online|
Jul 24, 2019, 04.22 PM IST
0Comments
ThinkStock Photos
LebenCareFoundersPitcure
Leben Care already made a market entry in India, Japan, China, Singapore, Africa and Australia through partnerships with distributors & ophthalmology centers across these countries.
DELHI: Singapore-based Leben Care has raised angel funding from IP Ventures to fight avoidable blindness. The company provides artificial-intelligence based diagnostic and screening solutions, primarily known for automated, fast and affordable retinal screening. Leben Care will use the funds to strengthen its product, sales and marketing teams.

Leben Care enables automated analysis of retina image using AI algorithms that can be used by technicians, nurses, optometrists to conduct basic screening with minimal specialist intervention, delivering real-time reports. The company will also cater to areas such as Glaucoma and age-related macular edema.

With over 700 million people worldwide at the risk of retinal damage, 200 thousand ophthalmologists and only 35 thousand retina experts, there is a significant supply gap that LebenCare intends to fill with its scalable technology.

Leben Care already made a market entry in India, Japan, China, Singapore, Africa and Australia through partnerships with distributors & ophthalmology centers across these countries.

Leben Care co-founder Nitin Srivastava said in a statement, “We are on a mission to fight avoidable blindness using AI and hope to make this technology available to millions who struggle to get access to basic screening. Our platform Netra.ai is intended to be the go to place for all Ophthalmology related AI solutions.”

Netra.AI platform provides valuable, automated, clinical insights on retina, blood vessels and lesions, aiding primary care workers in providing supportive information to ophthalmologist, retina specialist and other healthcare professionals using AI and deep machine learning.

Mitesh Shah, co-founder of IP Ventures said in a statement, “Leben Care has a competent team and some great strategic partnerships. We are very excited to partner with them.”
Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service